Male breast cancer in the Veterans Affairs population: A comparative analysis

Cancer

Volumn 109, Issue 8, 2007, Pages 1471-1477

  Nahleh, Zeina A ^a,b   Srikantiah, Roopa ^a,b   Safa, Malek ^a,b   Jazieh, Abdul Rahman ^a   Muhleman, Albert ^a,b   Komrokji, Rami ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Female; Hormone receptor status; Male

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; BREAST CANCER; BREAST CARCINOMA; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

AGE OF ONSET; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; REGISTRIES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 34247177951     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22589     Document Type: Review

References (18)

1. Giordano S, Cohen D, Buzdar A, Perkins G, Hortobagyi G. Breast carcinoma in men. A population based study. Cancer. 2004;101:51-57.
2. Giordano S, Buzdar A, Hortobagyi G. Breast cancer in men. Ann Intern Med. 2002;137:678-687.
3. Ewertz M, Holmberg L, Karjalainen S, Tretli S, Adami HO. Incidence of male breast cancer in Scandanavia 1943-1982. Int J Cancer. 1989;43:27-31.
4. Amir H, Makwaya CK, Moshiro C, Kwesigabo G. Carcinoma of the male breast: a sexually transmitted disease? East Afr Med J. 1996;73:187-190.
5. Yildirim E, Berberoglu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol. 1998;24:548-552.
6. Muir D, Kanthan R, Kanthan SC. Male versus female breast cancers: a population-based comparative immunohistochemical analysis. Arch Pathol Lab Med. 2003;127:36-41.
7. Nahleh Z, Girnius S. Male breast cancer: a gender issue. Nat Clin Pract Oncol. 2006;3:428-437.
8. Percy C, Van Holten V, Muir C. International Classification of Diseases in Oncology. Geneva: World Health Organization, 1990.
9. Nahleh Z. Hormonal therapy for male breast cancer: a different approach for a different disease. Cancer Treatment Rev. 2006;32:101-105.
10. American Cancer Society. Cancer Facts and Figures 2005. Atlanta, GA: American Cancer Society; 2005.
11. Samuelson MH. Breast cancer: not for women only. Lancet. 2006;367:605.
12. Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist. 2005;10:471-479.
13. Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85:629-639.
14. Wang-Rodriguez J, Cross K, Gallagher S, et al. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. Mod Pathol. 2002;15:853-861.
15. Munoz de Toro MM, Maffini MV, Kass L, Luque EH. Proliferative activity and steroid hormone receptor status in male breast carcinoma. J Steroid Biochem Mol Pathol. 1998;67:333-339.
16. Weber-Chappuis K, Bieri-Burger S, Hurlimann J. Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas. Eur J Cancer. 1996;32A:1686-1692.
17. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Matrons in breast cancer by race and ethnicity: update 2006. Ca Cancer J Clin. 2006;56:168-183.
18. Scott-Conner CE, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126:775-780; discussion, 780-781.